FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2153516407> ?p ?o ?g. }

• W2153516407 endingPage "130" @default.
• W2153516407 startingPage "121" @default.
• W2153516407 abstract "Article2 January 2003free access RelB is required for Peyer's patch development: differential regulation of p52–RelB by lymphotoxin and TNF Z.Buket Yilmaz Z.Buket Yilmaz Forschungszentrum Karlsruhe, Institute of Toxicology and Genetics, D-76021 Karlsruhe, Germany Search for more papers by this author Debra S. Weih Debra S. Weih Forschungszentrum Karlsruhe, Institute of Toxicology and Genetics, D-76021 Karlsruhe, Germany Search for more papers by this author Vallabhapurapu Sivakumar Vallabhapurapu Sivakumar Forschungszentrum Karlsruhe, Institute of Toxicology and Genetics, D-76021 Karlsruhe, Germany Search for more papers by this author Falk Weih Corresponding Author Falk Weih Forschungszentrum Karlsruhe, Institute of Toxicology and Genetics, D-76021 Karlsruhe, Germany Search for more papers by this author Z.Buket Yilmaz Z.Buket Yilmaz Forschungszentrum Karlsruhe, Institute of Toxicology and Genetics, D-76021 Karlsruhe, Germany Search for more papers by this author Debra S. Weih Debra S. Weih Forschungszentrum Karlsruhe, Institute of Toxicology and Genetics, D-76021 Karlsruhe, Germany Search for more papers by this author Vallabhapurapu Sivakumar Vallabhapurapu Sivakumar Forschungszentrum Karlsruhe, Institute of Toxicology and Genetics, D-76021 Karlsruhe, Germany Search for more papers by this author Falk Weih Corresponding Author Falk Weih Forschungszentrum Karlsruhe, Institute of Toxicology and Genetics, D-76021 Karlsruhe, Germany Search for more papers by this author Author Information Z.Buket Yilmaz1, Debra S. Weih1, Vallabhapurapu Sivakumar1 and Falk Weih 1 1Forschungszentrum Karlsruhe, Institute of Toxicology and Genetics, D-76021 Karlsruhe, Germany ‡D.S.Weih and V.Sivakumar contributed equally to this work *Corresponding author. E-mail: [email protected] The EMBO Journal (2003)22:121-130https://doi.org/10.1093/emboj/cdg004 PDFDownload PDF of article text and main figures. ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinked InMendeleyWechatReddit Figures & Info Targeted disruption of the Rel/NF-κB family members NF-κB2, encoding p100/p52, and RelB in mice results in anatomical defects of secondary lymphoid tissues. Here, we report that development of Peyer's patch (PP)-organizing centers is impaired in both NF-κB2- and RelB-deficient animals. IL-7-induced expression of lymphotoxin (LT) in intestinal cells, a crucial step in PP development, is not impaired in RelB-deficient embryos. LTβ receptor (LTβR)-deficient mice also lack PPs, and we demonstrate that LTβR signaling induces p52–RelB and classical p50–RelA heterodimers, while tumor necrosis factor (TNF) activates only RelA. LTβR-induced binding of p52–RelB requires the degradation of the inhibitory p52 precursor, p100, which is mediated by the NF-κB-inducing kinase (NIK) and the IκB kinase (IKK) complex subunit IKKα, but not IKKβ or IKKγ. Activation of RelA requires all three IKK subunits, but is independent of NIK. Finally, we show that TNF increases p100 levels, resulting in the specific inhibition of RelB DNA binding via the C-terminus of p100. Our data indicate an important role of p52–RelB heterodimers in lymphoid organ development downstream of LTβR, NIK and IKKα. Introduction The transcription factor NF-κB plays a pivotal role in immune responses, inflammation, the regulation of apoptosis and in cancer (Ghosh et al., 1998; Barkett and Gilmore, 1999; Hatada et al., 2000; Karin and Delhase, 2000; Karin and Lin, 2002; Karin et al., 2002). Five members of this family have been identified in vertebrates: NF-κB1 (encoding the precursor molecule p105 and the processed form p50), NF-κB2 (encoding the precursor p100 and the processed form p52), RelA (p65), RelB and c-Rel. In resting cells, Rel/NF-κB proteins associate with IκBs and are retained in the cytoplasm as inactive forms. A wide range of stimuli activate the IκB kinase (IKK) complex, which consists of two catalytic (IKKα and IKKβ) and one regulatory (IKKγ/NEMO) subunit, causing phosphorylation and ubiquitin-dependent degradation of the IκBs. Similarly, the precursor molecules p100 and p105 also sequester NF-κB in the cytoplasm via their C-terminal ankyrin repeats. Degradation of the IκBs and the p100/p105 precursors results in the nuclear translocation of Rel/NF-κB complexes and the regulation of κB target genes (Pahl, 1999; Karin and Ben-Neriah, 2000). The ‘classical’ NF-κB activity consists of p50–RelA heterodimers, other possible homo- and heterodimeric complexes can occur depending on cell type and activation status. RelB alone does not bind to DNA, but must dimerize with p50 or p52 to form transcriptional activators. In the mouse, high levels of RelB expression are restricted to specific regions of lymphoid organs. Interestingly, the basal κB-binding activity in thymus and spleen largely consists of p50–RelB and p52–RelB heterodimers, suggesting a role of RelB in the constitutive expression of κB-regulated genes in these tissues (Ryseck et al., 1996). Rel/NF-κB proteins have essential and distinct roles in development and function of the immune system (Attar et al., 1997; Gerondakis et al., 1999). RelB-deficient mice display a complex phenotype including multi-organ inflammation, splenomegaly, lack of lymph nodes and multi-focal defects in immune responses (Burkly et al., 1995; Weih et al., 1995, 1997). NF-κB1-deficient mice have specific B cell defects, but do not show major alterations in the architecture of lymphoid organs (Sha et al., 1995; Gerondakis et al., 1999). On the other hand, NF-κB2- and RelB-deficient mice have disorganized B and T cell areas, lack germinal centers (GCs) and splenic marginal zone structures, and show strongly reduced expression of homing chemokines (Caamaño et al., 1998; Franzoso et al., 1998; Poljak et al., 1999; Weih et al., 2001). The histological organization of Peyer's patches (PPs) distributed along the intestinal tract resembles other peripheral lymphoid organs, such as lymph nodes and spleen, with specialized structures like GCs, distinct interfollicular T cell areas and high endothelial venules (HEVs). Based on their anatomical location and their contribution to IgA production, PPs form the first front of mucosal immunity and play an important role in gastrointestinal immune defense (Griebel and Hein, 1996; Debard et al., 1999). The earliest marker for developing PPs is the appearance of VCAM-1+ PP organizing centers, which can be detected by whole-mount immunohistochemistry at ∼E15.5 of mouse embryonic development (Adachi et al., 1997). Recently, it was reported that IL-7Rα signaling through Jak3 in CD45+CD3− cells of the embryonic intestine is required for the production of LTα/β heterotrimers, resulting in VCAM-1 and ICAM-1 expression by LTβR-positive stromal cells (Nishikawa et al., 1998; Yoshida et al., 1999). Mice with targeted disruptions of genes encoding LTα, LTβ or LTβR, which lack PPs and peripheral lymph nodes (Debard et al., 1999; Fu and Chaplin, 1999; Matsumoto, 1999) support this finding. In contrast to LTβR signaling, activation of the p55 TNFR-I is not essential for PP organogenesis, but rather determines the cellular and structural organization of B cell follicles in secondary lymphoid tissues, whereas signaling through the p75 TNFR-II is completely dispensable for lymphoid organ development (Pasparakis et al., 1997; Matsumoto, 1999). The importance of the LTβR signaling pathway for PP and lymph node development is also shown in mice with a mutant NF-κB-inducing kinase (NIK) (Miyawaki et al., 1994; Shinkura et al., 1999), which is essential for LTβR, but dispensable for TNFR signaling to NF-κB (Matsushima et al., 2001; Yin et al., 2001). NIK was shown to phosphorylate and activate IKKα (Ling et al., 1998) and neither alymphoplasia (aly/aly) mice, which carry a point mutation resulting in an amino acid substitution in the C-terminal interaction domain of NIK (Shinkura et al., 1999), nor IKKα-deficient or IKKαAA knockin animals (NIK phosphorylation sites replaced by alanines) develop VCAM-1+ PP organizing centers (Miyawaki et al., 1994; Matsushima et al., 2001; Senftleben et al., 2001). In the present study, we analyzed the role of RelB and its heterodimerization partners p50 and p52 during the early steps of PP development, focusing on LT and TNF signaling pathways. We show that activation of LTβR triggers processing of the inhibitory p100 precursor to p52 dependent on NIK and IKKα resulting in the induction of p52–RelB heterodimers, whereas TNF signaling inhibits κB binding of RelB via the increased production of p100. Our observations suggest an important role for p52–RelB heterodimers in PP organogenesis downstream of LTβR, NIK and IKKα. Results Lack of PPs in relB−/− and nfkb2−/− mice Histological examination of adult mice revealed that RelB is required for PP development. Whereas wild-type mice had several easily detectable PPs, serial sections of Swiss roles of the small intestine did not reveal any histological evidence of rudimentary PPs in relB−/− mice. While nfkb1−/− mice had small PPs with a poorly developed microarchitecture, nfkb2−/− mice also lacked PPs and only occasionally had lymphoid aggregates in the small intestine (data not shown). To examine whether PP development is blocked at an early stage in nfkb2−/− and relB−/− mice, we stained whole intestines from newborn mice for VCAM-1. Figure 1 shows that VCAM-1+ PP organizing centers formed normally in wild-type (Figure 1A) and nfkb1−/− mice (Figure 1B), but were absent in nfkb2−/− (Figure 1C) and relB−/− animals (Figure 1D). Thus, both p52/p100 and RelB are essential for the development of PPs, whereas the p50 subunit of NF-κB plays only a minor role in this process. Figure 1.Lack of VCAM-1-positive cell clusters in nfkb2−/− and relB−/− mice. Whole-mount anti-VCAM-1 immunohistochemical staining of intestines from newborn wild-type (A), nfkb1−/− (B), nfkb2−/− (C) and relB−/− mice (D). Arrowheads mark VCAM-1-positive spots in wild-type and nfkb1−/− mice. Ce, cecum. Immunohistochemical detection of RelB (brown staining) in developing PPs from wild-type E16.5 (E) and E18.5 (F) embryos. (G) Staining of adult wild-type PP with anti-RelB antibody revealed high expression in the interfollicular region (IFR), the subepithelial dome (SED) and the follicle-associated epithelium (FAE). Reduced numbers of RelB-positive cells were also found in GCs. (H) RelB is expressed in stromal cells of PPs. Immuno histochemical detection of RelB in a PP from a lethally irradiated wild-type mouse reconstituted with relB−/− bone marrow. All sections were counterstained with hematoxylin. Original magnifications: (E and F), 40×; (G), 10×; (H), 20×. Download figure Download PowerPoint Analysis of RelB expression in PPs Immunohistochemical analysis of intestine sections from wild-type E16.5 (Figure 1E) and E18.5 embryos (Figure 1F) revealed RelB expression in the developing PP anlage. Fully developed PPs from adult wild-type mice showed strong RelB expression in the interfollicular region (IFR), the subepithelial dome (SED) and the follicle-associated epithelium (FAE). Fewer RelB+ cells were also observed in follicles and GCs (Figure 1G). The analysis of lethally irradiated wild-type mice after adoptive transfer of relB−/− bone marrow revealed that RelB in hematopoietic cells was not required for the maintenance of PP structures and that RelB was also expressed in stromal cells of PPs. While RelB levels were clearly reduced in the IFRs, which predominantly harbor T cells and dendritic cells, RelB+ cells were still detected throughout the chimeric PPs, in particular in the FAE close to the follicle-associated crypt (Figure 1H). Adoptive transfers of wild-type fetal liver or bone marrow cells failed to restore PPs in irradiated newborn or adult relB−/− mice, respectively (data not shown). Together, these results suggest that RelB in non-hematopoietic cells is required for normal PP development. Normal IL-7-induced LTα expression in relB−/− embryonic intestinal cells Developing PPs can be detected as early as E15.5 d.p.c. (Adachi et al., 1997) and RT–PCR analysis of intestines revealed RelB mRNA expression in wild-type E14.5 embryos with increasing levels at E16.5 and E18.5, while no expression was detected in relB−/− mice (Figure 2A). NF-κB2 mRNA was also expressed in E14.5 embryonic intestines (data not shown). The induction of LTα/β heterotrimers downstream of the IL-7Rα is crucial for the expression of VCAM-1 and ICAM-1 by LTβR-positive stromal cells in the developing PP (Yoshida et al., 1999). Analysis of various embryonic stages did not reveal significant defects in mRNA levels of IL-7 and the IL-7Rα chain or LTβR and TNFR-I in relB−/− intestine compared with wild-type littermates (data not shown). LTα and LTβ expression was examined in intestinal cell cultures from relB+/+ and relB−/− E16.5 embryos. IL-7 treatment strongly upregulated LTα mRNA levels in these cultures whereas LTβ expression was only slightly induced. However, no significant difference was observed between relB−/− mice and wild-type controls (Figure 2B). These data indicate the presence of normal numbers of CD45+CD3−IL-7Rα+ cells and an intact pathway upstream of LTβR in relB−/− embryonic intestine. Figure 2.(A) RT–PCR analysis of relB mRNA levels in intestine from wild-type (+/+) and RelB-deficient (−/−) embryos at E14.5, E16.5 and E18.5 d.p.c. (B) IL-7-induced expression of lta and ltb mRNA in intestine from relB+/+ and relB−/− E16.5 embryos. Intestinal cell cultures were either induced with IL-7 (+) or left untreated (−). After 24 h, total RNA was prepared and analyzed by RT–PCR. Expression of β-actin in (A) and (B) is shown as a control. Download figure Download PowerPoint LTβR, but not TNFR, signaling induces RelB complexes independent of RelA Using different primary and established mouse fibroblast lines as a model system for signaling events in stromal cells during early PP development, we examined whether the activation of LTβR, as compared with TNFR, results in the induction of RelB complexes. TNF treatment resulted in strong NF-κB induction after 20 min (complex I), which was maximal at 1 h. In contrast, the kinetics of NF-κB activation after LTβR triggering by the agonistic anti-LTβR monoclonal antibody (mAb) AC.H6 (Rennert et al., 1998) were significantly slower, reaching maximal levels only after 4–8 h (Figure 3A). In addition, LTβR signaling induced a faster migrating heterodimeric complex (II) at 4 and 8 h time points whereas the κB-binding pattern after TNF treatment was rather constant. Dissection of the different Rel/NF-κB complexes in supershift experiments revealed that TNF almost exclusively induced binding of RelA (complex I), whereas LTβR signaling resulted in the activation of both RelA and p52–RelB heterodimers (complex I and II). Activation of LTβR also increased binding of complex III, which consisted of p50–p50 homodimers (Figure 3B). We only observed weak induction of c-Rel complexes in cells treated with anti-LTβR mAb although we cannot rule out the possibility that they did not bind efficiently under our experimental conditions. Figure 3.Induction of RelA complexes and p52–RelB heterodimers by TNFR and LTβR signaling, respectively. (A) Wild-type fibroblasts were either left untreated (un) or treated for 1, 4 and 8 h with TNF or agonistic anti-LTβR mAb and nuclear extracts were analyzed in EMSAs. (B) Extracts from 8 h TNF- or anti-LTβR-treated fibroblasts were used to identify nuclear complexes using following Abs: lane 1, pre-immune serum (p.i.); lane 2, α-RelA; lane 3, α-RelA + α-RelB; lane 4, α-RelA + α-p50; lane 5, α-RelA + α-p50 + α-p52; lane 6, α-cRel. (C) RelA is not essential for the induction of RelB complexes downstream of LTβR. Wild-type and relA−/− fibroblasts were left untreated (un) or were treated for 4 and 8 h with anti-LTβR mAb. RelB-specific Abs were used to confirm the identity of complex II. Download figure Download PowerPoint To substantiate the results from Figure 3A and B, we performed additional supershift experiments with nuclear extracts from relB−/−, nfkb1−/− and nfkb2−/− mouse embryonic fibroblasts (MEFs) treated with TNF or stimulated with anti-LTβR mAb (see Supplementary figure 1, available at The EMBO Journal Online). In summary, while complex I was not affected, complex II was absent from relB−/− and nfkb2−/− fibroblasts, but still induced by anti-LTβR mAb treatment in nfkb1−/− cells. The data further show that LTβR-induced binding of p50–RelA (complex I) was abolished in nfkb1−/− fibroblasts. Interestingly, in nfkb1−/− cells, TNF-induced complex I consisted predominantly of p52–RelA heterodimers. Moreover, co-immunoprecipitation experiments provide physical evidence for the formation of p52–RelB heterodimers in response to LTβR signaling (see Supplementary figure 2). Binding of p52–RelB heterodimers in anti-LTβR-stimulated fibroblasts was preceded by the induction of RelA complexes. Since it was reported that relB gene transcription is regulated by NF-κB (Bren et al., 2001), we analyzed LTβR-mediated activation of NF-κB complexes in relA−/− fibroblasts. Figure 3C shows that while formation of complex I was abolished in relA−/− cells, RelB heterodimers (complex II) were still induced. Together, these data indicate that activation of LTβR, in contrast to TNFR, results in the specific induction of p52–RelB heterodimers and that RelA is not absolutely required for the induction of RelB complexes downstream of LTβR. LTβR-induced binding of p52–RelB heterodimers requires IKKα and IKKβ, but not IKKγ To asses which subunits of the IKK complex are involved in LTβR-mediated induction of p52–RelB heterodimers, we compared TNF- and anti-LTβR-stimulated activation of Rel/NF-κB complexes in IKKα-, IKKβ- and IKKγ-deficient fibroblasts. Figure 4A shows that IKKα was absolutely required for LTβR-mediated induction of complex II, but dispensable for TNF-induced binding of NF-κB. The lack of IKKα also resulted in reduced, but still detectable, binding of p50–RelA heterodimers (complex I) after LTβR signaling. IKKβ-deficient fibroblasts also showed an almost complete loss of complex II and strongly reduced binding of complex I. In contrast, LTβR signaling still induced binding of p52–RelB (complex II) and p50–p50 (complex III) in IKKγ-deficient fibroblasts while κB binding was abolished in TNF-treated cells (Figure 4A and B). Quantification of complex II in anti-LTβR-treated IKKγ-deficient cells revealed an ∼3-fold reduction compared with wild-type controls (data not shown). Figure 4.Analysis of κB binding after LTβR and TNFR signaling in IKK-deficient and aly/aly fibroblasts. (A) IKKα-, IKKβ- and IKKγ-deficient fibroblasts were either left untreated (un) or treated for 1, 4 and 8 h with anti-LTβR mAb or TNF, and nuclear extracts were analyzed in EMSAs. (B) LTβR signaling induces p52–RelB complexes independent of IKKγ. The identity of complexes in nuclear extracts from IKKγ-deficient fibroblasts treated for 8 h with anti-LTβR mAb was determined with the following Abs: lane 1, p.i. serum; lane 2, α-RelA; lane 3, α-RelA + α-RelB; lane 4, α-p50; lane 5, α-p50 + α-p52. (C) NIK is required for the induction of p52–RelB heterodimers. MEFs from wild-type and aly/aly mice were treated for 1, 4 and 8 h with anti-LTβR mAb and nuclear extracts were analyzed for κB binding. Download figure Download PowerPoint To address the role of NIK in the induction of RelB complexes, we compared MEFs from wild-type and aly/aly mice. Similar to IKKα-deficient cells, aly/aly MEFs completely lacked binding of p52–RelB heterodimers (complex II), whereas the anti-LTβR-induced binding of p50–RelA (complex I) was not reduced (Figure 4C). Thus, binding of p52–RelB heterodimers downstream of LTβR requires NIK, IKKα and IKKβ, but is independent of IKKγ. IKKα and NIK, but not IKKβ or IKKγ, regulate p100 processing downstream of LTβR Since LTβR-induced binding of p52–RelB heterodimers may be regulated by the generation of p52 from its precursor molecule p100, we examined p100, p52 and RelB protein levels in wild-type and IKK-deficient fibroblasts that were stimulated with anti-LTβR mAb for different time periods. Whereas IKKα was absolutely required for LTβR-induced processing of p100 to p52, IKKβ was required for normal p100/p52 basal levels, but dispensable for the degradation of the p100 precursor (Figure 5A). Consistent with the results from the electrophoretic mobility shift assays (EMSAs), processing of p100 and accumulation of p52 still occurred in fibroblasts lacking IKKγ although with slower kinetics compared with wild-type cells. Interestingly, the kinetics of p100 processing, the generation of p52 and the increase in RelB levels perfectly coincided with the induced p52–RelB binding (see Figure 3A for 4 and 8 h time points). Similar to p52, basal RelB protein levels depended on IKKα and IKKβ, but were unaffected by the lack of IKKγ (Figure 5A). p100 processing and p52 accumulation downstream of LTβR also required NIK, whereas RelB protein levels were normal in aly/aly MEFs (Figure 5B). Figure 5.p100 processing in wild-type, IKK-deficient and aly/aly fibroblasts upon LTβR signaling. Western blot analysis of p100, p52 and RelB protein levels in whole-cell extracts from wild-type, IKKα-, IKKβ- and IKKγ-deficient fibroblasts (A) as well as from wild-type and aly/aly MEFs (B) after stimulation with anti-LTβR mAb for 1, 4 and 8 h. β-actin protein levels are shown as a loading control. *, unspecific band. Download figure Download PowerPoint TNF induces p100 and RelB levels and promotes the formation of p100–RelB complexes The C-terminal ankyrin repeat domain of p100, also called IκBδ, can function as a potent inhibitor of RelB complexes (Dobrzanski et al., 1995; Solan et al., 2002). To examine whether the lack of TNF-induced RelB DNA binding (see Figure 3B) is due to the lack of p100 degradation and/or insufficient production of p52 that can heterodimerize with RelB, we analyzed p100 and p52 protein levels in extracts from TNF-treated wild-type fibroblasts. TNF induction resulted in a strong increase of the p100 precursor in both cytoplasm and nucleus. TNF also markedly increased cytoplasmic and nuclear RelB, but had very little effect on p52 levels (Figure 6A). Immunofluorescent staining of fibroblasts with an Ab specific for the C-terminus of p100 confirmed the increase in cytoplasmic and nuclear p100 levels upon TNF stimulation (Figure 6B). To examine whether RelB and p100 interact in vivo immunoprecipitations were performed. Reciprocal experiments with RelB- and p100-specific Abs showed that endogenous RelB was bound to p100 in TNF-stimulated fibroblasts (Figure 6C). This interaction was also observed when nuclear fractions instead of whole-cell extracts were used, but it did not occur in anti-LTβR-treated cells (Supplementary figure 2; data not shown). Figure 6.TNF induction of fibroblasts results in increased p100 levels in both cytoplasm and nucleus. (A) Western blot analysis of p100, p52 and RelB levels in cytoplasmic and nuclear extracts from wild-type fibroblasts that were treated with TNF for the indicated time points. Quality of fractions was tested with Abs against cytoplasmic LDH or nuclear c-Jun proteins. XT, extract; *, unspecific band. (B) Immunofluorescent (FITC) staining of untreated (a) and TNF-induced (b) wild-type fibroblasts with an Ab specific for the C-terminus of p100. Staining of p100-deficient fibroblasts is shown as a negative control (c). The inset shows nuclei stained with DAPI. (d) DAPI staining of the TNF-induced fibroblasts from (b). (C) RelB and p100 interact in TNF-simulated fibroblasts. Fibroblasts were induced with TNF and cells were lysed under native conditions. Immunoprecipitations (IP) were carried out with (+) or without (−) lysates using either p100- or RelB-specific Abs. The precipitated material was separated by SDS–PAGE and analyzed in western blots (WB) for p100 and RelB levels. Ig, immunoglobulins. Download figure Download PowerPoint The C-terminal domain of p100 represses RelB DNA binding downstream of TNFR RelB requires p50 or p52 as a dimerization partner to bind to DNA. We therefore analyzed whether the limited availability of the p52 subunit in TNF-treated fibroblasts was responsible for the lack of nuclear RelB DNA binding. Fibroblasts that were transfected with a p52 or p50 expression plasmid and stimulated with TNF showed a strong increase of p52 and p50 homodimer binding, respectively. However, no RelB heterodimers were detected, indicating that κB binding of RelB is blocked despite sufficient levels of heterodimerization partners (data not shown). Another possibility, as suggested by our co-immunoprecipitation experiments, is that the TNF-induced increase of p100 specifically blocks RelB DNA binding. To address this point, we used MEFs that lack the p100 precursor, but still express p52 (Ishikawa et al., 1997). The TNF-induced NF-κB activity was dramatically increased in p100-deficient cells and consisted predominantly of RelB heterodimers, whereas the amount of RelA complexes was similar to wild-type controls. In striking contrast, κB binding in MEFs from mice lacking the C-terminal ankyrin domain of p105, but still expressing p50 (Ishikawa et al., 1998), consisted almost exclusively of RelA complexes (Figure 7A). In both p100−/− and p105−/− MEFs, TNF-induced RelB protein levels were comparable with controls (data not shown). Quantification of TNF-induced κB binding revealed that the ratio of RelB/RelA complexes was increased 10-fold in p100-deficient MEFs and decreased 4-fold in cells lacking p105 (Figure 7B). Together, these results demonstrate that in TNF-induced fibroblasts, the C-terminal domain of p100, but not the corresponding portion of p105, specifically represses RelB DNA binding. Figure 7.The C-terminal domain of p100 specifically represses RelB DNA binding in TNF-induced fibroblasts. (A) MEFs from wild-type, p100−/− and p105−/− mice were stimulated for 8 h and nuclear extracts were analyzed for NF-κB activity by EMSAs. Complexes were identified with specific Abs. (B) Quantification of the experiment shown above. The amount of complex retained by the respective Abs in the slot (arrowhead) was quantified, corrected for the signal in samples treated with p.i. serum and the amount of RelB DNA binding in wild-type MEFs was set to one. Download figure Download PowerPoint Discussion RelB- and p52-deficient mice lack PPs Here, we report relB and nfkb2 mRNA expression in embryonic small intestine, RelB protein staining in E16.5 developing PPs and the lack of PPs in both p52- and RelB-deficient mice. The loss of PP structures is reminiscent of mice lacking LTα, LTβ, LTβR or NIK. In contrast, TNF and TNFR-I knockout mice have PPs although their number and size are clearly reduced (Fu and Chaplin, 1999; Matsumoto, 1999). One explanation is that activation of p52–RelB complexes downstream of LTβR is essential for the formation of PP anlagen, whereas p50 complexes and the TNF signaling pathway are not required but rather contribute to the full PP developmental program. The lack of VCAM-1+ PP-organizing centers in RelB- and p52-deficient, but not in p50-deficient, embryonic intestines supports our view. Paxian et al. also reported that p50-deficient mice have a reduced number and size of PPs and that p52-deficient mice lack PPs. It was suggested that p52 is not required for PP development in principle based on the presence of IL-7Rα mRNA-positive structures (Paxian et al., 2002). IL-7Rα expression may stem from isolated lymphoid follicles in the small intestine, which also contain IL-7Rα+ cells (Hamada et al., 2002). The mere presence of these cells does not indicate normal PP development since they are also found in Jak3-deficient mice, which lack both VCAM-1+-organizing centers and developed PPs (Adachi et al., 1998). To our knowledge, no mutant has yet been described that has VCAM-1+ PP anlagen but lacks PPs. RelB expression in the embryonic intestine most likely stems from stromal cells since lymphocytes colonize the PP anlage not before E18 (Adachi et al., 1998; Hashi et al., 2001). A crucial step at this stage is the IL-7-induced expression of LTα and LTβ in IL-7Rα+ intestinal cells (Yoshida et al., 1999), which was comparable in wild-type and relB−/− embryonic intestinal cultures. Since IL-7Rα+ cells are the only source of LTα and LTβ at this crucial developmental stage (Yoshida et al., 1999), we conclude that these hematopoietic inducers of PP-organizing centers are present and functional in relB−/− intestine, suggesting a stromal defect downstream of LTβR. Activation of p52–RelB heterodimers downstream of LTβR regulates PP development Since LTβR is also expressed in stromal cells of developing PPs (Honda et al., 2001), we used fibroblasts as a model system for LTβR and TNFR signaling. We demonstrated that TNF rapidly induces binding of RelA whereas LTβR signaling stimulates binding of RelA and, with delayed kinetics (2–4 h), also of p52–RelB (Figure 3). RelB heterodimers may have been unnoticed in previous studies (Mackay et al., 1996; VanArsdale et al., 1997; Smith et al., 2001; Yin et al., 2001) due to the undetectable binding of p52–RelB at earlier time points and/or the strong and preceding induction of RelA. Recently, it was shown that transcription of the relB gene is regulated by NF-κB, possibly via identified RelA- and RelB-binding sites in the promoter region (Bren et al., 2001). A role for RelA in lymphoid organ development has been shown by the analysis of mice deficient for both TNFR-I and" @default.
• W2153516407 created "2016-06-24" @default.
• W2153516407 creator A5003578541 @default.
• W2153516407 creator A5005567259 @default.
• W2153516407 creator A5035014542 @default.
• W2153516407 creator A5077808441 @default.
• W2153516407 date "2003-01-02" @default.
• W2153516407 modified "2023-10-03" @default.
• W2153516407 title "RelB is required for Peyer's patch development: differential regulation of p52-RelB by lymphotoxin and TNF" @default.
• W2153516407 cites W1495579988 @default.
• W2153516407 cites W1501881225 @default.
• W2153516407 cites W155134865 @default.
• W2153516407 cites W1558901013 @default.
• W2153516407 cites W1579102917 @default.
• W2153516407 cites W1588586944 @default.
• W2153516407 cites W1860281141 @default.
• W2153516407 cites W1884284628 @default.
• W2153516407 cites W1906564878 @default.
• W2153516407 cites W1919878195 @default.
• W2153516407 cites W1970444129 @default.
• W2153516407 cites W1972195950 @default.
• W2153516407 cites W1972379965 @default.
• W2153516407 cites W1978019581 @default.
• W2153516407 cites W1987097007 @default.
• W2153516407 cites W1987531976 @default.
• W2153516407 cites W1993620754 @default.
• W2153516407 cites W1993906107 @default.
• W2153516407 cites W2007456673 @default.
• W2153516407 cites W2009550948 @default.
• W2153516407 cites W2010896319 @default.
• W2153516407 cites W2016730049 @default.
• W2153516407 cites W2018718597 @default.
• W2153516407 cites W2028910347 @default.
• W2153516407 cites W2031795268 @default.
• W2153516407 cites W2032531389 @default.
• W2153516407 cites W2033810895 @default.
• W2153516407 cites W2035616122 @default.
• W2153516407 cites W2046265685 @default.
• W2153516407 cites W2046553655 @default.
• W2153516407 cites W2058714321 @default.
• W2153516407 cites W2069356140 @default.
• W2153516407 cites W2069952825 @default.
• W2153516407 cites W2071082533 @default.
• W2153516407 cites W2073292142 @default.
• W2153516407 cites W2076980233 @default.
• W2153516407 cites W2077575210 @default.
• W2153516407 cites W2078627220 @default.
• W2153516407 cites W2090369370 @default.
• W2153516407 cites W2101580628 @default.
• W2153516407 cites W2103944436 @default.
• W2153516407 cites W2106877484 @default.
• W2153516407 cites W2111828502 @default.
• W2153516407 cites W2129971695 @default.
• W2153516407 cites W2138004606 @default.
• W2153516407 cites W2140472565 @default.
• W2153516407 cites W2142770698 @default.
• W2153516407 cites W2147507133 @default.
• W2153516407 cites W2147921405 @default.
• W2153516407 cites W2148186925 @default.
• W2153516407 cites W2154155318 @default.
• W2153516407 cites W2159722075 @default.
• W2153516407 cites W2168317635 @default.
• W2153516407 cites W2171501214 @default.
• W2153516407 cites W2290936009 @default.
• W2153516407 cites W2312571711 @default.
• W2153516407 cites W2396556520 @default.
• W2153516407 cites W2411211523 @default.
• W2153516407 cites W2470223656 @default.
• W2153516407 cites W293684771 @default.
• W2153516407 cites W2999065750 @default.
• W2153516407 cites W78369961 @default.
• W2153516407 cites W2418861082 @default.
• W2153516407 doi "https://doi.org/10.1093/emboj/cdg004" @default.
• W2153516407 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/140043" @default.
• W2153516407 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12505990" @default.
• W2153516407 hasPublicationYear "2003" @default.
• W2153516407 type Work @default.
• W2153516407 sameAs 2153516407 @default.
• W2153516407 citedByCount "201" @default.
• W2153516407 countsByYear W21535164072012 @default.
• W2153516407 countsByYear W21535164072013 @default.
• W2153516407 countsByYear W21535164072014 @default.
• W2153516407 countsByYear W21535164072015 @default.
• W2153516407 countsByYear W21535164072016 @default.
• W2153516407 countsByYear W21535164072017 @default.
• W2153516407 countsByYear W21535164072018 @default.
• W2153516407 countsByYear W21535164072019 @default.
• W2153516407 countsByYear W21535164072020 @default.
• W2153516407 countsByYear W21535164072021 @default.
• W2153516407 countsByYear W21535164072022 @default.
• W2153516407 countsByYear W21535164072023 @default.
• W2153516407 crossrefType "journal-article" @default.
• W2153516407 hasAuthorship W2153516407A5003578541 @default.
• W2153516407 hasAuthorship W2153516407A5005567259 @default.
• W2153516407 hasAuthorship W2153516407A5035014542 @default.
• W2153516407 hasAuthorship W2153516407A5077808441 @default.
• W2153516407 hasBestOaLocation W21535164071 @default.
• W2153516407 hasConcept C103813035 @default.

• next